US pharmaceutical stocks fell across the board, as Trump plans to significantly lower drug prices raised industry concerns.

Including companies like Lilly, Johnson & Johnson, and Merck, pharmaceutical stocks in the US all fell. Earlier, President Trump announced plans to significantly lower prescription drug prices in the US, a move that sparked concerns among investors about the potential impact on pharmaceutical companies' revenues.